from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0093c/-

LFCtreatmentdescriptionclass of inhibitor

-1.225

Amikacinug/mL Amikacintranslation

-1.190

Cap5-10ug/mL Capreomycintranslation

-1.261

Rox10-50 ug/mL Roxithromycintranslation

-1.030

SM2-5 ug/mL Streptomycintranslation

-1.153

Tet5-10 ug/mL Tetracyclinetranslation

0.655

Rif0.2-5ug/mL Rifampicintranscription

-0.607

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.997

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.722

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.200

CPZ10-50 ug/mL Chlorpromazinerespiration

0.715

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.773

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.707

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.448

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.503

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.765

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.686

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.848

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.092

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.010

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.328

KCN5-20 ug/mL Potassium cyaniderespiration

0.314

NaN30.2-2 mM Sodium aziderespiration

-0.039

Nigericin50 uM Nigericinrespiration

0.512

TRC10-150 ug/mL Triclosanrespiration

1.221

TRZ10-25 ug/mL Thioridazinerespiration

-0.244

Valinomycin0.5-10 uM Valinomycinrespiration

-1.488

ZnSO42 mM ZnSO4respiration

0.484

menadione6-10 ug/mL Menadionerespiration

0.404

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.277

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.934

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.110

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.440

NRP_1Non-replicating persistence stage 1dosRassociated

-0.648

Amp0.2mg/mL AmpicillincellWall

0.043

Cephalexin20-100 ug/mL CephalexincellWall

-0.400

Cerulenin0.32-5 ug/mL CerulenincellWall

0.902

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.150

EMB10-20 ug/mL EthambutolcellWall

-1.270

Eta12-40 ug/mL EthionamidecellWall

-1.452

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.468

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.334

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.015

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.086

BZA0.12 mg/mL BenzamidearomaticAmides

0.253

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.433

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.328

H2O24 mM hydrogen peroxideDNAdamaging

-1.089

Levo10 ug/mL LevofloxacinDNAdamaging

-0.386

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.299

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.724

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.427

UVUV-irradiationDNAdamaging

0.739

ARP41-4 ug/mL Antitubercular compound ARP4?

0.205

Antimycin12.5-50 ug/mL Antimycin A?

-0.046

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.896

PA_110-50 ug/mL Antitubercular compound PA-1?

0.935

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.288

PA8240.2-2 ug/mL PA-824?

0.283

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.229

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.398

Verapamil50 uM Verapamil?

0.863

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.004

methoxatin10-20 ug/mL Methoxatin?